cursory info: evo vp's only/primary transaction
Post# of 30027
(Total Views: 602)
Posted On: 05/29/2019 12:33:38 AM
.jpg)
cursory info:
evo vp's only/primary transaction is a $50M funding of Precision Biologics in 2015.
June 3, Todos presents at Alz Solutions Conference.
Key notes include
1. diagnostic progress as a highlighted discussion, the presence of ADDF president Howard Fillit, 9:05am - 9:15am Optimism and Lessons: Advances in Alzheimer’s Diagnostics and Treatment
Howard Fillit, MD, Founding Executive Director and Chief Science Officer, ADDF
2. Our regA+ David Weild 3:30pm - 3:45pm A Solution to the ‘Valley of Death’ in Alzheimer’s Finance
David Weild, Chairman & CEO, Weild & Co, Co-founder & Vice Chairman, InvestAcure, PBC
3. Paula Trzpecz (who interestingly is not listed as having any association with Coeptis and is presenting 10:00am - 10:15am LymPro: The Immune-based Blood Test for Alzheimer’s
Paula Trzepacz, PhD, Scientific Advisor for Alzheimer’s Diagnostics, Todos Medical),
Maybe we're looking for NGN Captital to perform a raise for TODOS. And I think even if we don't get any Gates money, we've got a consolation prize. Investacure is a socially conscious investment app. Like acorn, it invests your spare change, just in a cause you identify with, in this case alzheimers. So a passive continuous go fund me. Interesting concept. I feel like Weild is too mad scientist, not enough closer.
https://www.investacure.com/asc/?gclid=Cj0KCQ...QoEALw_wcB
evo vp's only/primary transaction is a $50M funding of Precision Biologics in 2015.
June 3, Todos presents at Alz Solutions Conference.
Key notes include
1. diagnostic progress as a highlighted discussion, the presence of ADDF president Howard Fillit, 9:05am - 9:15am Optimism and Lessons: Advances in Alzheimer’s Diagnostics and Treatment
Howard Fillit, MD, Founding Executive Director and Chief Science Officer, ADDF
2. Our regA+ David Weild 3:30pm - 3:45pm A Solution to the ‘Valley of Death’ in Alzheimer’s Finance
David Weild, Chairman & CEO, Weild & Co, Co-founder & Vice Chairman, InvestAcure, PBC
3. Paula Trzpecz (who interestingly is not listed as having any association with Coeptis and is presenting 10:00am - 10:15am LymPro: The Immune-based Blood Test for Alzheimer’s
Paula Trzepacz, PhD, Scientific Advisor for Alzheimer’s Diagnostics, Todos Medical),
Maybe we're looking for NGN Captital to perform a raise for TODOS. And I think even if we don't get any Gates money, we've got a consolation prize. Investacure is a socially conscious investment app. Like acorn, it invests your spare change, just in a cause you identify with, in this case alzheimers. So a passive continuous go fund me. Interesting concept. I feel like Weild is too mad scientist, not enough closer.
https://www.investacure.com/asc/?gclid=Cj0KCQ...QoEALw_wcB
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼